Galectin Therapeutics | GALT - Kewajiban Lancar

Keuangan

USD

USD 27.66M

USD 25.6M

USD 27.29M

Kewajiban Lancar

USD 14.62M

USD 71.74M

Dividen - Hasil

0

USD -9.17M

USD -7.43M

14

Eps Laba Per Saham

USD -0.2

Modal Dan Cadangan

USD -83.87M

Beban Bunga Utang

USD 1.27M

Pendapatan Bunga

USD -2.71M

USD 93.42M

Kapitalisasi Pasar

USD 230.3M

Batas Pemasukan

USD -12.37M

Biaya Operasional

USD 11.29M

Laba Operasional

USD -11.29M

Modal Saham Biasa

USD 61K

Laba Sebelum Pajak

USD -12.37M

Pendapatan Penjualan

4.02

Beban Penjualan Dan Administrasi

USD 1.48M

Kreditur Perdagangan

USD 3.7M

	Kewajiban Lancar	Perubahan		Tanggal
AbbVie	USD 41.64B		458M	2026-06
Bristol-Myers Squibb	USD 18.66B		499M	2026-06
Galectin Therapeutics	USD 14.62M		1.98M	2024-06
Gilead Sciences	USD 11.02B		1.54B	2026-06
Immunic	USD 38.36M		7.74M	2026-03
Incyte	USD 1.31B		177.55M	2026-06
Merck	USD 27.73B		786M	2026-06